NanoHive Medical
Private Company
Total funding raised: $6.5M
Overview
NanoHive Medical is an innovator in the orthopedic spine sector, focusing on next-generation spinal fusion implants. Its core technology is the Soft Titanium® lattice, a patented, 3D-printed structure that mimics cancellous bone, offering a modulus of elasticity comparable to traditional polymer (PEEK) implants while maintaining titanium's strength and biocompatibility. The company has a commercial portfolio of cervical and lumbar interbody devices and is exploring future 'smart implant' capabilities. With recent Series C funding and distribution expansion, NanoHive is positioned to grow its market share in the competitive spinal implants industry.
Technology Platform
Proprietary Soft Titanium® technology featuring a 3D-printed, biomimetic rhombic dodecahedron lattice structure designed to reduce implant stiffness, promote bone on-growth/ingrowth, and allow for superior post-operative imaging.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
NanoHive competes in the crowded spinal implants market against major players like Medtronic, Stryker, NuVasive, and Zimmer Biomet, which offer a wide range of PEEK and titanium devices. Its differentiation is its proprietary Soft Titanium® lattice, which aims to combine the best attributes of both material types, competing directly with other advanced porous metal implants from companies like 4WEB Medical and Osseus Fusion Systems.